IPO Issue Details
Issue Price / Price Band₹90 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size1,600 Shares per Lot
Total Issue Size40,99,200 shares (agg. up to ₹37 Cr)
Issue TypeBook Built Issue
Sale Type / CategoryFresh Capital
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenWed, 31 Dec 2025
Subscription CloseFri, 02 Jan 2026
Anchor AllotmentTue, 30 Dec 2025
Basis of AllotmentMon, 05 Jan 2026
Initiation of RefundsTue, 06 Jan 2026
Credit of Shares to DematTue, 06 Jan 2026
Listing DateWed, 07 Jan 2026
UPI Mandate Deadline5:00 PM on 02 Jan 2026 (Day 3)
Application & Investment Details
Retail — Min (2 Lots)₹2,88,000 — 3,200 shares
Retail — Max (13 Lots)₹1,872,000 (13 Lots)
HNI — Min (3 Lots)₹4,32,000 — 4,800 shares
EPS (Pre-IPO)₹8.15
EPS (Post-IPO)₹7.94
P/E Ratio (Pre-IPO)11.04x
P/E Ratio (Post-IPO)11.33x
Net Offer to Public38,92,800 shares (agg. up to ₹35 Cr)
Reserved for Market Maker2,06,400 shares (agg. up to ₹2 Cr)
Pre-IPO Promoter Holding1,10,00,000 shares
Post-IPO Promoter Holding1,50,99,200 shares
About Modern Diagnostic & Research Centre Ltd
Incorporated in 1985, Modern Diagnostic & Research Centre Limited (MDRC) is a diagnostic chain in India, offering a comprehensive range of pathology and radiology services.The company provides reliable diagnostic tests, home specimen collection, online reports, and customized test packages for institutional customers and patients based on their specific needs.The company operates 21 centers (17 labs, 4 diagnostic centers) across 8 states, offering diagnostic services like ultrasound, CT, MRI, X-ray, ECG, PFT, and specialized labs for heart and neuro care.Services:Pathology:MDRC provides a wide array of tests, including high-end molecular diagnostics, cytogenetics, and specialized panels for genetic disorders and cancer.Radiology:The centre offers advanced imaging services such as MRI, CT scans, ultrasound, and digital X-rays, utilizing state-of-the-art equipment like a 3-Tesla MRI machine and a 128-slice CT scanner.Home Sample Collection:MDRC offers home blood sample collection services in several cities, providing convenience for patients unable to visit the centre.As on February 28, 2025, the company has total 570 Employees including Consultants and doctors.Competitive Strengths:Experienced Promoter and Management TeamComprehensive diagnostics provider delivering all-in-one solution at cost-effective pricesFocus on quality and customer serviceCentralized information technology platform
Objects of the Issue
Modern Diagnostic & Research Centre Ltd proposes to utilise the net proceeds from the Issue for the following objects:
1
Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories
20.69
2
Funding Working Capital Requirement
8.00
3
Repayment of certain outstanding borrowings availed by the Company
1.00
4
General Corporate Expenses
Shareholding & Lock-in
Pre-IPO Promoter Holding
1,10,00,000 shares
Post-IPO Promoter Holding
1,50,99,200 shares